+13.1%
GSK vs SITM
+47.5%
-34.4%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SITM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | -9.4% | +14.4% | +4.9% |
| 7D | +4.9% | -19.5% | +24.5% | +4.7% |
| 30D | +9.9% | -43.2% | +53.1% | +9.8% |
| 3M | +0.2% | -30.8% | +31.0% | -0.3% |
| 6M | +2.3% | -28.6% | +30.9% | +0.1% |
| YTD | +7.1% | +14.2% | -7.1% | -0.3% |
| 1Y | +13.1% | +44.4% | -31.3% | +3.9% |
| All | +13.1% | +47.5% | -34.4% | +3.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SITM.
Daily Out/Under-Performance
Portfolio return minus SITM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SITM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SITM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling